ericarditis and acute pericardial effusion have been occasionally associated with influenza A infections. Chronic pericardial effusion is an infrequent complication that has not been described in adults but can appear following acute disease. Conservative management is the first-line treatment; however surgery can be used for recurrent effusions or in the event of complications.
CASE REPORT
In this case report, we describe a 62-year-old man who presented to our emergency department with respiratory failure and a depressed level of consciousness during an epidemic seasonal flu. He had experienced progressive dyspnea, general malaise, asthenia, and anorexia in the previous six weeks. His medical history was significant for obesity, hypertension, diabetes type 2, and occasional use of tobacco and alcohol. On admission, he had a temperature of 36.5 ºC, blood pressure of 95/60 mmHg, and pulse of 102/minute. Pulsus paradoxicus and jugular venous distention were found on physical examination. He had muffled cardiac sounds with crepitus in the right pulmonary base. His respiratory status was compromised and his oxy-hemoglobin saturation fell below 80%, requiring noninvasive ventilatory support in the Intensive Care Unit (ICU).
Notable abnormal laboratory values included a white blood cell count of 7.500/mL, a creatinine phosphokinase peak level of 71.7 IU/L, a troponin level of 0.03 ng/dL and a myoglobin level of 59 ng/ mL. An electrocardiogram showed low voltages, sinus rhythm and re-demonstrated an old right bundle block. A chest radiograph showed diffuse signs of cardiac failure and cardiomegaly. Computed tomography ( Fig. 1) Oral oseltamivir therapy was initiated at a dosage of 75 mg every 12 h for ten days. Tachypnea and cardiac failure gradually improved, and the patient was discharged from the ICU after 5 days.
The patient was also tested for other bacterial (including acid fast bacteria), fungal, and viral respiratory agents in the blood cultures, urine, serum and bronchoalveolar lavage (organisms tested=Legionella, Streptococcus pneumoniae, Mycoplasma pneumoniae, rhinovirus, adenovirus, enterovirus, parainfluenza virus and respiratory syncytial virus) and all the results were negative. Multiplex RT-PCR with microarray technology was used to detect respiratory viruses antibody was 2.86 U/mL (NR: 0-10). The rheumatoid factor was <20 UI/mL (NR: 0-33).
Tumor biomarkers were also measured. The carcinoembrionary antigen level was (CEA) 1.42 ng/ml (NR: 0-4.6), alpha fetoprotein was 1.29 ng/ml (NR: 0-6.2), CA-15.3 was 29.83 U/ml (NR: 0-30), CA-125 was 29.09 U/ml (NR: 0-35), and PSA was 0.499 ng/ ml (NR: 0-4). Thyroid stimulating hormone (TSH) was 0.82 µU/ml (NR: 0.34-5.6).
The patient was seen again 10.5 months after discharge. There was some remaining chronic pericardial effusion (Fig. 2) , asthenia, effort dyspnea, weight loss (22 kilograms) and anorexia. Pericardial drainage was performed when physical disability was present. No infectious etiology was found during follow-up and tumor and inflammatory markers were all negative. Treatment with colchicine (2 mg on the first day, followed by 0.5 mg twice daily for six months) and low doses of corticosteroids (prednisone 0.2 mg/kg/ day for six months) were not effective and a pericardiectomy was performed to prevent recurrent effusions.
DISCUSSION
The findings in this case report suggest that the pericardial effusion associated with influenza virus A (H1N1)/2009 infection was caused by direct tropism of the virus. [1] Pericarditis and pericardial effusion have been observed as a complication of influenza A (H1N1) infections in children. [2, 3] Cardiac involvement is usually reported to occur between 4 and 9 days after the onset of influenza symptoms and is characterized by worsening dyspnea, electrocardiography abnormalities (i.e., ST elevation and Q waves), elevation of cardiac enzymes, and impaired left ventricular function. [4] In some cases, pericardial effusion may result in cardiac tamponade. [5] Cardiac events generally occur as a clinical consequence of the primary respiratory infection. [6] In our case, cardiac involvement occurred silently or late in the course of the infection. The timing of the cardiac involvement, in combination with detection of the virus in the pericardial fluid, strongly suggests a direct effect of influenza virus A (H1N1)/2009 on the pericardium. Viral tropism for myocardial tissue may be enhanced by the cytokine cascade and by enhancing or modifying viral receptors on the endothelial cells lining the myocardial tissue. Immune-mediated pathology in the case of infectious pericarditis has been suspected [7] but in our patient, the immunology study suggested a chronic state of inflammation.
Our case report demonstrates that pericardial effusion may occur as a result of infection with influenzavirus A (H1N1)/2009. Puzelli et al. [8] suggest that influenza virus A (H1N1)/2009 is more commonly associated with severe forms of cardiac involvement than the other circulating influenza virus strains. There are no reports that show that metapneumonvirus A has pathogenic effects on the pericardium but infection with this virus may potentiate co-existing cardiac disease. The absence of high C-reactive protein levels or other markers of acute inflammation could be explained by the study by Pankuweit et al., [9] in which autoreactive pericarditis led to an elevation of cytokines (interleukin 6 and 8) and interferon gamma that was only detected in the pericardial fluid but not in sera. Although influenza virus A (H1N1)/2009 rarely leads to cardiac complications, pericardial effusion and other severe cardiac events need to be considered when this virus is suspected. Furthermore, the above data strongly highlights the importance of early diagnosis and treatment. If medical treatment fails to be effective, surgical pericardiectomy may be an effective alternative.
